RaySearch Laboratories AB (publ)
Other OTCTotal Valuation
RaySearch Laboratories AB (publ) carries a market capitalization of 534.58M, placing it among publicly traded companies globally. Its enterprise value stands at 7.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 534.58M |
| Enterprise Value | 7.05B |
Share Statistics
RaySearch Laboratories AB (publ) currently has 33.62M shares outstanding.
| Shares Outstanding | 33.62M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
RaySearch Laboratories AB (publ) trades at a trailing price-to-earnings ratio of 33.02. The price-to-sales ratio is 5.54, and the price-to-book ratio stands at 8.75.
| PE Ratio | 33.02 |
| PS Ratio | 5.54 |
| PB Ratio | 8.75 |
| P/TBV Ratio | 35.01 |
| P/FCF Ratio | 15.89 |
| P/OCF Ratio | 17.08 |
Enterprise Valuation
On an enterprise value basis, RaySearch Laboratories AB (publ) trades at an EV/EBITDA multiple of 25.46 and an EV/FCF ratio of 15.92. The EV/Sales ratio of 5.55 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.46 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.55 |
| EV / EBITDA | 25.46 |
| EV / EBIT | 25.46 |
| EV / FCF | 15.92 |
Financial Position
RaySearch Laboratories AB (publ) maintains a current ratio of 1.29, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.29 |
| Quick Ratio | 0.34 |
| Debt / Equity | 45.56 |
| Debt / EBITDA | 1.30 |
| Interest Coverage | N/A |
Financial Efficiency
RaySearch Laboratories AB (publ) posts a return on equity of 26.02 and a return on invested capital of 17.90.
| Return on Equity (ROE) | 26.02 |
| Return on Assets (ROA) | 11.19 |
| Return on Invested Capital (ROIC) | 17.90 |
| Return on Capital Employed (ROCE) | 17.56 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.35 |
Taxes
Over the trailing twelve months, RaySearch Laboratories AB (publ) has paid 58.30M in income taxes, reflecting an effective tax rate of 21.53.
| Income Tax | 58.30M |
| Effective Tax Rate | 21.53 |
Stock Price Statistics
RaySearch Laboratories AB (publ)'s stock has declined approximately -35.74792% over the past 52 weeks. The 50-day moving average sits at 18.42, while the 200-day moving average is 21.46.
| Beta (5Y) | N/A |
| 52-Week Price Change | -35.74792% |
| 50-Day Moving Average | 18.42 |
| 200-Day Moving Average | 21.46 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, RaySearch Laboratories AB (publ) generated 1.27B in revenue and converted that into 213.00M in net income, yielding earnings per share of 6.20. EBITDA reached 276.70M, while operating income came in at 276.70M.
| Revenue | 1.27B |
| Gross Profit | 1.18B |
| Operating Income | 276.70M |
| Pretax Income | 270.80M |
| Net Income | 213.00M |
| EBITDA | 276.70M |
| EBIT | 276.70M |
| Earnings Per Share (EPS) | 6.20 |
Balance Sheet
RaySearch Laboratories AB (publ) holds 213.10M in cash and equivalents against 359.20M in total debt, resulting in a net debt position of -213.10M. Total book value stands at 788.40M, with working capital of 179.60M providing operational flexibility.
| Cash & Cash Equivalents | 213.10M |
| Total Debt | 359.20M |
| Net Debt | -213.10M |
| Equity (Book Value) | 788.40M |
| Book Value Per Share | 23.45 |
| Working Capital | 179.60M |
Cash Flow
RaySearch Laboratories AB (publ) produced 411.80M in operating cash flow over the past twelve months. After subtracting -30.70M in capital expenditures, free cash flow totaled 381.10M - equivalent to 11.12 per share.
| Operating Cash Flow | 411.80M |
| Capital Expenditures | -30.70M |
| Free Cash Flow | 381.10M |
| FCF Per Share | 11.12 |
Margins
RaySearch Laboratories AB (publ) operates with a gross margin of 93.03, reflecting its pricing power and cost economics. The operating margin of 21.78 and net profit margin of 16.77 provide insight into operational efficiency.
| Gross Margin | 93.03 |
| Operating Margin | 21.78 |
| Pretax Margin | 21.32 |
| Profit Margin | 16.77 |
| EBITDA Margin | 21.78 |
Dividends & Yields
The company's payout ratio of 64.52 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 4.00 |
| Dividend Yield | N/A |
| Payout Ratio | 64.52 |
| Shareholder Yield | 5.17 |
| FCF Yield | 6.29 |
Scores
RaySearch Laboratories AB (publ) posts an Altman Z-Score of 5.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.98 |